Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of superficial basal cell carcinomas after treatment with imiquimod 5% cream or vehicle for apoptosis and lymphocyte phenotyping.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] - 1 Dec 2003

Sullivan Tory P, Dearaujo Tami, Vincek Vladimir, Berman Brian

Abstract excerpt

OBJECTIVE: To characterize the immune response and the apoptotic pathways that result in regression of imiquimod-treated basal cell carcinomas (BCCs). METHODS: The trial was conducted as an open-label, matched controlled, nonrandomized study. Twelve patients were assigned as either active-treatme...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aminoquinolines
Share to Antineoplastic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Apoptosis

Share to Carcinoma, Basal Cell

Share to Lymphocytes

Share to Phenotype

Share to Skin Neoplasms

Source

Identifiers

PMID: 14725659
DOI: 10.1111/j.1524-4725.2003.29399.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-14725659-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Evaluation of superficial basal cell carcinomas after treatment with imiquimod 5% cream or vehicle for apoptosis and lymphocyte phenotyping.PMID 14725659Read ↗

Mechanisms Underlying Imiquimod-Induced Regression of Basal Cell Carcinoma In VivoSemantic proximity Read ↗

Efficacy of imiquimod for the expression of Bcl-2, Ki67, p53 and basal cell carcinoma apoptosisSemantic proximity Read ↗

The SINS trial: a randomised controlled trial of excisional surgery versus imiquimod 5% cream for nodular and superficial basal cell carcinoma.Semantic proximity Read ↗

Imiquimod activates p53-dependent apoptosis in a human basal cell carcinoma cell line.Semantic proximity Read ↗

Gene expression profiling of cutaneous wound healingSemantic proximity Read ↗

Immunophenotypic analysis of the p53 gene in non-melanoma skin cancer and correlation with apoptosis and cell proliferation.Semantic proximity Read ↗

Specific betapapillomaviruses associated with squamous cell carcinoma of the skin inhibit UVB-induced apoptosis of primary human keratinocytesSemantic proximity Read ↗

New therapeutic options for actinic keratosis and basal cell carcinoma.Semantic proximity Read ↗

Gene expression in actinic keratoses: pharmacological modulation by imiquimodSemantic proximity Read ↗

In vivo and in situ modulation of the expression of genes involved in metastasis and angiogenesis in a patient treated with topical imiquimod for melanoma skin metastasesSemantic proximity Read ↗

SURGICAL ANALYSIS AND BIOLOGICAL BEHAVIOUR OF 2277 BASAL CELL CARCINOMASSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.